Practical reading from Professor Paul Lee and the Lincolnshire Hip Clinic team — across hip replacement, Arthrosamid, ChondroFiller, PRP and the wider world of hip and groin pain.
ChondroFiller is an injectable collagen scaffold that polymerises in the hip to draw the patient's own repair cells to worn cartilage. In a cohort of 26 patients with focal lesions and mild arthritis, 81% achieved good or excellent outcomes at three to five years.
Four hip cartilage repair techniques now carry 2025 data for younger adults; AMIC achieved zero hip replacement conversions versus 2–32.6% for microfracture, with durability determined by defect size and joint stability.
Hip osteoarthritis X-ray staging describes cartilage loss from grade 0 to 4 but does not predict pain severity, disease progression, or surgical need; identical grades produce widely different functional outcomes.
Hip cartilage damaged by femoroacetabular impingement cannot repair itself; early treatment with ChondroFiller scaffold achieved 90–93% freedom from hip replacement at five years, but outcomes were poor if osteoarthritis was already present.
Five-year follow-up data show ChondroFiller injection sustained good or excellent cartilage repair in 81% of hip patients with focal defects and minimal osteoarthritis, with mean functional improvement of 33 Harris Hip Score points.
AMIC, conducted in theatre, rebuilds hip cartilage from the subchondral bone upward; ChondroFiller, an outpatient injection, applies a collagen scaffold from above. Defect geometry, hip joint health grade, surgical fitness, and type of repair needed—structural rebuilding or cushioning support—determine which approach suits each patient.
Hip cartilage cannot self-repair because it lacks blood supply; untreated lesions deepen rather than stabilise, making early specialist assessment critical to preserving treatment options.
ChondroFiller records zero serious adverse effects across 19,000+ cases since 2013; swelling and pain peak at 24–48 hours post-injection as the collagen scaffold triggers normal tissue inflammation, then ease off.
Hip cartilage does not regenerate once meaningfully damaged. A preservation window exists only whilst damage remains focal; once progressive osteoarthritis, structural problems left uncorrected, or delayed diagnosis spreads it through the joint, repair becomes unsafe and hip replacement is the appropriate pathway.
Lincolnshire Hip Clinic
Led by Professor Paul Lee
Start with a free, non-medical discovery call with our team. We will tell you, honestly, which of our pathways — surgical or non-surgical — fits your situation. No GP referral, no pressure to proceed.
What we offer
